Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 04-2015 | 04-2014 | 04-2013 | 04-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -14,082 | -19,542 | -9,416 | -15,712 |
| Depreciation Amortization | N/A | 823 | 151 | 149 | 207 |
| Accounts receivable | N/A | -793 | 519 | -246 | -75 |
| Other Working Capital | N/A | 1,931 | -1,471 | -196 | -486 |
| Other Operating Activity | 0 | 2,372 | 11,081 | 4,787 | 7,789 |
| Operating Cash Flow | $N/A | $-9,749 | $-9,262 | $-4,921 | $-8,278 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 2 | -10 | -13 | -13 |
| Purchase Of Investment | N/A | -55,142 | N/A | N/A | N/A |
| Sale Of Investment | N/A | 14,320 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -105 | -137 | -135 | -248 |
| Other Investing Activity | 0 | -106 | -137 | -135 | -248 |
| Investing Cash Flow | $N/A | $-40,926 | $-147 | $-148 | $-261 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 4,514 |
| Debt Issued | N/A | 172 | 141 | 103 | 838 |
| Debt Repayment | N/A | N/A | N/A | N/A | -8,000 |
| Common Stock Issued | N/A | 544 | 62,044 | 0 | 8,734 |
| Common Stock Repurchased | N/A | N/A | N/A | -380 | N/A |
| Other Financing Activity | 0 | -435 | 4,760 | 4,250 | 3,382 |
| Financing Cash Flow | $N/A | $281 | $66,946 | $3,973 | $9,467 |
| Beginning Cash Position | N/A | 58,321 | 784 | 1,880 | 952 |
| End Cash Position | N/A | 7,927 | 58,321 | 784 | 1,880 |
| Net Cash Flow | $N/A | $-50,394 | $57,537 | $-1,096 | $928 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -9,749 | -9,262 | -4,921 | -8,278 |
| Capital Expenditure | N/A | -4 | -10 | -17 | -18 |
| Free Cash Flow | 0 | -9,753 | -9,271 | -4,939 | -8,296 |